OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) Director Thomas Kosasa acquired 268,817 shares of the business’s stock in a transaction on Monday, May 18th. The stock was acquired at an average price of $0.93 per share, with a total value of $249,999.81. Following the acquisition, the director owned 16,930,144 shares in the company, valued at $15,745,033.92. The trade was a 1.61% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link.
Thomas Kosasa also recently made the following trade(s):
- On Thursday, April 23rd, Thomas Kosasa acquired 280,898 shares of OneMedNet stock. The stock was acquired at an average price of $0.89 per share, with a total value of $249,999.22.
OneMedNet Trading Up 10.4%
ONMD stock traded up $0.08 during mid-day trading on Wednesday, reaching $0.87. The company’s stock had a trading volume of 176,615 shares, compared to its average volume of 2,833,610. The stock has a market cap of $47.09 million, a PE ratio of -12.36 and a beta of 1.25. OneMedNet Corporation has a fifty-two week low of $0.31 and a fifty-two week high of $4.22. The company’s 50 day moving average is $0.89 and its two-hundred day moving average is $1.06.
Hedge Funds Weigh In On OneMedNet
Institutional investors have recently bought and sold shares of the company. Ashton Thomas Private Wealth LLC purchased a new position in OneMedNet during the third quarter worth about $25,000. HRT Financial LP purchased a new position in OneMedNet during the fourth quarter worth about $32,000. Virtu Financial LLC purchased a new position in OneMedNet during the fourth quarter worth about $48,000. Jane Street Group LLC acquired a new stake in shares of OneMedNet during the fourth quarter valued at about $119,000. Finally, State Street Corp increased its position in shares of OneMedNet by 41.5% during the fourth quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after acquiring an additional 34,200 shares during the last quarter. 0.95% of the stock is owned by hedge funds and other institutional investors.
OneMedNet Company Profile
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Featured Articles
- Five stocks we like better than OneMedNet
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
